bioAffinity Technologies Granted Hong Kong Patent for Lung Cancer Diagnostic Technology

Filing content

The company received a patent from the Hong Kong Intellectual Property Department for its lung cancer diagnostic platform technology, strengthening its intellectual property protection in the Asian market.